Glaxo Leaps Into Chantix Smackdown

Pfizer’s smoking-cessation drug Chantix has taken a few licks this week, with federal regulators limiting the drug’s use by pilots and air-traffic controllers. Just in time for the holiday weekend, GlaxoSmithKline has jumped into the fray, offering its own smoking cessation product — free of... [read full story]